Indian Pharma
- All
- News
- Videos
-
Why Trump's 100% Pharma Tariffs May Not Impact Indian Drugmakers Much
US President Donald Trump has said his administration will impose 100 per cent import tariffs on branded or patented pharmaceutical drugs from October 1, unless the pharma companies have or are building their manufacturing units in America.
-
Trump's 100% Tariff On Pharma Will Not Impact Generic Makers: Industry Leaders
Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines.
-
Trump Declares 100% Tariff On Pharma Imports From October 1, India May Be Hit
US President Donald Trump has announced tariffs of up to 100 per cent on imports of branded and patented pharmaceutical products from October 1. India's pharmaceuticals sector, one of the most dependent domestic industries on trade with America.
-
Expand Export Markets, Boost Local Demand: India's Plan For Trump Tariffs
Faced with the United States' 50 per cent tariff on exports, India has reached out to dozens of nations to up trade in key sectors like textiles and chemicals. The goal - offset a potential $48 billion loss in export of goods and services to the US.
-
Any Tariff On Pharma Will Hit India, As 40% Exports Go To US: Report
Imposing tariffs on the pharmaceutical Industry will significantly impact the earnings of Indian pharma companies, as nearly 40 per cent of India's total pharma exports are directed to the US market, according to a report by SBI Research.
-
Trump Raises Tariffs To 50%: What It Means For India
US President Donald Trump today announced an additional 25 per cent tariff on goods coming from India as penalty for what he called New Delhi's continued buying of Russian oil.
-
Nifty Falls Below 25,000, Sensex Slips Under 82,000 In Early Trade
Indian stock markets came under pressure on Friday as selling by Foreign Portfolio Investors (FPIs) weighed on investor sentiment.
-
Sensex, Nifty Open Flat After US Federal Policy Decision
The Indian benchmark indices opened almost flat on Thursday over the US Federal Reserve policy decision and weak Asian cues, as selling was seen in the IT, PSU bank, FMCG and pharma sectors in the early trade.
-
Sensex Falls 231 Points, Nifty Downs 49 Points Amid Mixed Global Cues
The domestic benchmark indices opened lower on Friday amid mixed global cues as selling was seen in the IT, financial services and pharma sectors in the early trade.
-
Sensex Opens 265 Points Higher, Nifty Climbs 89 Points In Early Trade
The Indian equity benchmark indices opened higher on Friday amid positive global cues, as buying was seen in the IT, pharma and auto sectors in the early trade.
-
"Could Have Been...": Russia Denies Attack On Indian Firm's Kyiv Warehouse
Russia has refuted allegations by Ukraine that a Russian missile struck the warehouse of an Indian pharma firm in Kyiv last week.
-
Russian Missile Strikes Indian Pharma Firm's Kyiv Warehouse: Ukraine
A Russian missile struck the warehouse of an Indian pharmaceutical company in Kyiv, Ukraine said today. The country's embassy in India alleged Russia "deliberately" targeted Indian businesses in Ukraine.
-
Sensex Opens Lower But Holds Above 74,000-Mark Day After Rally
The Indian benchmark indices opened marginally low on Friday amid weak global cues, as selling was seen in the IT, PSU Bank and pharma sectors in the early trade.
-
Indian Share Market Rings Into New Year With Flat Trajectory
The domestic benchmark indices opened flat on Wednesday as selling was seen in auto, PSU bank, financial service, pharma and metal sectors on Nifty.
-
AI To Help Indian Pharma Industry To Pivot On Innovation, Reach 130 Billion In Size By 2030
Technological advancements like AI, machine learning and precision medicine are set to revolutionise drug discovery, manufacturing and patient care.
-
Why Trump's 100% Pharma Tariffs May Not Impact Indian Drugmakers Much
US President Donald Trump has said his administration will impose 100 per cent import tariffs on branded or patented pharmaceutical drugs from October 1, unless the pharma companies have or are building their manufacturing units in America.
-
Trump's 100% Tariff On Pharma Will Not Impact Generic Makers: Industry Leaders
Indian Pharmaceutical Alliance (IPA) on Friday said US President Donald Trump's move to impose 100 per cent import tariffs on pharmaceutical drugs from October 1 will impact only patented and branded products, not generic medicines.
-
Trump Declares 100% Tariff On Pharma Imports From October 1, India May Be Hit
US President Donald Trump has announced tariffs of up to 100 per cent on imports of branded and patented pharmaceutical products from October 1. India's pharmaceuticals sector, one of the most dependent domestic industries on trade with America.
-
Expand Export Markets, Boost Local Demand: India's Plan For Trump Tariffs
Faced with the United States' 50 per cent tariff on exports, India has reached out to dozens of nations to up trade in key sectors like textiles and chemicals. The goal - offset a potential $48 billion loss in export of goods and services to the US.
-
Any Tariff On Pharma Will Hit India, As 40% Exports Go To US: Report
Imposing tariffs on the pharmaceutical Industry will significantly impact the earnings of Indian pharma companies, as nearly 40 per cent of India's total pharma exports are directed to the US market, according to a report by SBI Research.
-
Trump Raises Tariffs To 50%: What It Means For India
US President Donald Trump today announced an additional 25 per cent tariff on goods coming from India as penalty for what he called New Delhi's continued buying of Russian oil.
-
Nifty Falls Below 25,000, Sensex Slips Under 82,000 In Early Trade
Indian stock markets came under pressure on Friday as selling by Foreign Portfolio Investors (FPIs) weighed on investor sentiment.
-
Sensex, Nifty Open Flat After US Federal Policy Decision
The Indian benchmark indices opened almost flat on Thursday over the US Federal Reserve policy decision and weak Asian cues, as selling was seen in the IT, PSU bank, FMCG and pharma sectors in the early trade.
-
Sensex Falls 231 Points, Nifty Downs 49 Points Amid Mixed Global Cues
The domestic benchmark indices opened lower on Friday amid mixed global cues as selling was seen in the IT, financial services and pharma sectors in the early trade.
-
Sensex Opens 265 Points Higher, Nifty Climbs 89 Points In Early Trade
The Indian equity benchmark indices opened higher on Friday amid positive global cues, as buying was seen in the IT, pharma and auto sectors in the early trade.
-
"Could Have Been...": Russia Denies Attack On Indian Firm's Kyiv Warehouse
Russia has refuted allegations by Ukraine that a Russian missile struck the warehouse of an Indian pharma firm in Kyiv last week.
-
Russian Missile Strikes Indian Pharma Firm's Kyiv Warehouse: Ukraine
A Russian missile struck the warehouse of an Indian pharmaceutical company in Kyiv, Ukraine said today. The country's embassy in India alleged Russia "deliberately" targeted Indian businesses in Ukraine.
-
Sensex Opens Lower But Holds Above 74,000-Mark Day After Rally
The Indian benchmark indices opened marginally low on Friday amid weak global cues, as selling was seen in the IT, PSU Bank and pharma sectors in the early trade.
-
Indian Share Market Rings Into New Year With Flat Trajectory
The domestic benchmark indices opened flat on Wednesday as selling was seen in auto, PSU bank, financial service, pharma and metal sectors on Nifty.
-
AI To Help Indian Pharma Industry To Pivot On Innovation, Reach 130 Billion In Size By 2030
Technological advancements like AI, machine learning and precision medicine are set to revolutionise drug discovery, manufacturing and patient care.
